ACADIAN ASSET MANAGEMENT LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$560
-100.0%
30,153
-96.6%
0.00%
-95.2%
Q3 2022$11,431,000
+17.2%
891,057
-36.0%
0.06%
+26.0%
Q2 2022$9,755,000
-22.6%
1,391,566
-8.6%
0.05%
-3.8%
Q1 2022$12,611,000
+35.4%
1,521,709
+10.6%
0.05%
+48.6%
Q4 2021$9,312,000
+22.5%
1,375,966
-4.1%
0.04%
+20.7%
Q3 2021$7,601,000
+21.8%
1,434,950
+32.2%
0.03%
+26.1%
Q2 2021$6,239,000
+12.3%
1,085,091
-9.9%
0.02%
+4.5%
Q1 2021$5,554,000
+126.5%
1,204,678
+64.1%
0.02%
+144.4%
Q4 2020$2,452,000
+18.3%
734,029
+5.1%
0.01%0.0%
Q3 2020$2,073,000
-35.9%
698,327
-0.3%
0.01%
-35.7%
Q2 2020$3,236,000
-2.7%
700,561
-18.9%
0.01%
-26.3%
Q1 2020$3,327,000
+43.2%
864,147
+39.4%
0.02%
+72.7%
Q4 2019$2,324,000
+99.8%
619,731
+182.9%
0.01%
+120.0%
Q3 2019$1,163,000
+296.9%
219,102
+186.7%
0.01%
+400.0%
Q2 2019$293,000
+229.2%
76,416
+224.6%
0.00%
Q3 2018$89,000
-81.3%
23,544
-84.6%
0.00%
-100.0%
Q2 2018$476,000
+3561.5%
152,638
+3547.3%
0.00%
Q3 2015$13,000
+550.0%
4,185
+660.9%
0.00%
Q2 2015$2,0005500.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders